These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [2-methionine phenothiazine derivatives with antibacterial action]. Păunescu L; Oiţă N; Fişel S; Năstasă V Rev Med Chir Soc Med Nat Iasi; 1982; 86(3):475-9. PubMed ID: 7170497 [No Abstract] [Full Text] [Related]
23. Stability of ricobendazole in aqueous solutions. Wu Z; Tucker IG; Razzak M; Medlicott NJ J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190 [TBL] [Abstract][Full Text] [Related]
24. Kinetics of drug decomposition. Part XXXI. Autoxidation of narcotine in aqueous solutions. Pawelczyk E; Zajac M; Remisz M Pol J Pharmacol Pharm; 1974; 26(5):569-74. PubMed ID: 4427819 [No Abstract] [Full Text] [Related]
25. EVIDENCE FOR THE COMPLEXING OF OXYGEN BY PHENOTHIAZINES. MARTIN HF; PRICE S; GUDZINOWICZ BJ Arch Biochem Biophys; 1963 Nov; 103():196-205. PubMed ID: 14084582 [No Abstract] [Full Text] [Related]
27. [Study of ointments with antihistamincs. 1]. Rub-Saidac A; Bugnariu O; Filipas V; Ciocănelea V; Oprean I Pharmazie; 1970 Mar; 25(3):194-6. PubMed ID: 4393873 [No Abstract] [Full Text] [Related]
28. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part V. Mechanism of sulfadimidine solvolysis. Zajac M Pol J Pharmacol Pharm; 1977; 29(6):683-8. PubMed ID: 600867 [TBL] [Abstract][Full Text] [Related]
29. The use of mixed-mode ion-exchange solid phase extraction to characterize pharmaceutical drug degradation. Landis MS J Pharm Biomed Anal; 2007 Sep; 44(5):1029-39. PubMed ID: 17553650 [TBL] [Abstract][Full Text] [Related]
30. The determination of sulphoxide in degraded phenothiazine formulations by difference spectrophotometry. Davidson AG J Pharm Pharmacol; 1978 Jul; 30(7):410-4. PubMed ID: 27605 [TBL] [Abstract][Full Text] [Related]
31. [Polarographic oxidation of phenothiazine substances in acetonitrile]. Nĕmec I; Sulcová N; Waisser K Cesk Farm; 1979 Mar; 28(2):59-61. PubMed ID: 509549 [No Abstract] [Full Text] [Related]
32. Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode. El-Yazbi FA; Hammud HH; Sonji NM; Sonji GM Pharmazie; 2008 Jun; 63(6):420-7. PubMed ID: 18604984 [TBL] [Abstract][Full Text] [Related]
33. [Kinetics of the degradation process in tetracycline solutions]. Faith L; Georch D; Springer V Cesk Farm; 1972 Oct; 21(8):353-60. PubMed ID: 5084371 [No Abstract] [Full Text] [Related]
34. Kinetics of drug decomposition. Part XXXVI. Stability of 10-(1'-methyl-4'-piperazinylpropyl)-phenothiazine derivatives on the grounds of kinetics of thermal degradation and Hammett equation. Pawelczyk E; Marciniec B; Matlak B Pol J Pharmacol Pharm; 1975; 27(3):317-25. PubMed ID: 1144210 [TBL] [Abstract][Full Text] [Related]
35. The determination of phenothiazine sulphoxides in degraded phenothiazine formulations [proceedings]. Davidson AG J Pharm Pharmacol; 1977 Dec; 29 Suppl():13P. PubMed ID: 22641 [No Abstract] [Full Text] [Related]
36. Oxidative degradation of pharmaceutically important phenothiazines I: Isolation and identification of oxidation products of promethazine. Underberg WJ J Pharm Sci; 1978 Aug; 67(8):1128-31. PubMed ID: 671251 [TBL] [Abstract][Full Text] [Related]
37. Analytical aspects of the stabilization of drugs in pharmaceutical formulations. Raether G Acta Pharm Hung; 1991 Sep; 61(5):231-8. PubMed ID: 1785352 [TBL] [Abstract][Full Text] [Related]
38. Kinetic studies of the ceruloplasmin-catalyzed oxidation of phenothiazine derivatives. Lovstad RA Biochem Pharmacol; 1975 Feb; 24(4):475-8. PubMed ID: 234238 [No Abstract] [Full Text] [Related]
39. Urinary metabolites of 10-[3'-(4"-methylpiperazinyl)-propyl]-phenothiazine (perazine) in psychiatric patients. I. Isolation, identification and determination of metabolites. Breyer U Biochem Pharmacol; 1969 Apr; 18(4):777-88. PubMed ID: 5788518 [No Abstract] [Full Text] [Related]